David Kirske - Net Worth and Insider Trading

David Kirske Net Worth

The estimated net worth of David Kirske is at least $155,684 dollars as of 2024-05-02. David Kirske is the EVP, CFO of CTI BioPharma Corp and owns about 17,127 shares of CTI BioPharma Corp (CTIC) stock worth over $155,684. Details can be seen in David Kirske's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Kirske has not made any transactions after 2023-01-03 and currently still holds the listed stock(s).

Transaction Summary of David Kirske

To

David Kirske Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Kirske owns 1 companies in total, including CTI BioPharma Corp (CTIC) .

Click here to see the complete history of David Kirske’s form 4 insider trades.

Insider Ownership Summary of David Kirske

Ticker Comapny Transaction Date Type of Owner
CTIC CTI BioPharma Corp 2023-01-03 EVP & Chief Financial Officer

David Kirske Latest Holdings Summary

David Kirske currently owns a total of 1 stock. David Kirske owns 17,127 shares of CTI BioPharma Corp (CTIC) as of January 3, 2023, with a value of $155,684.

Latest Holdings of David Kirske

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CTIC CTI BioPharma Corp 2023-01-03 17,127 9.09 155,684

Holding Weightings of David Kirske


David Kirske Form 4 Trading Tracker

According to the SEC Form 4 filings, David Kirske has made a total of 6 transactions in CTI BioPharma Corp (CTIC) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in CTI BioPharma Corp is the sale of 54,042 shares on January 3, 2023, which brought David Kirske around $324,792.

Insider Trading History of David Kirske

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Kirske Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Kirske Ownership Network

Ownership Network List of David Kirske

No Data

Ownership Network Relation of David Kirske


David Kirske Owned Company Details

What does CTI BioPharma Corp do?

Who are the key executives at CTI BioPharma Corp?

David Kirske is the EVP & Chief Financial Officer of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , director & President and CEO Adam R Craig , and other: See Explanation of Responses Biotechnology Value Fund L P .

CTI BioPharma Corp (CTIC) Insider Trades Summary

Over the past 18 months, David Kirske made 1 insider transaction in CTI BioPharma Corp (CTIC) with a net sale of 54,042. Other recent insider transactions involving CTI BioPharma Corp (CTIC) include a net sale of 327,617 shares made by Adam R Craig , a net sale of 100,000 shares made by James K Fong , and a net sale of 91,500 shares made by Michael A Metzger .

In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 573,159 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 573,159 shares.

CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CTI BioPharma Corp Insider Transactions

No Available Data

David Kirske Mailing Address

Above is the net worth, insider trading, and ownership report for David Kirske. You might contact David Kirske via mailing address: C/o Cti Biopharma Corp., 3101 Western Ave., Suite 600, Seattle Wa 98121.

Discussions on David Kirske

No discussions yet.